Gene Symbol | Gene ID | Gene Info |
---|---|---|
Bptf
|
ENSMUSG00000040481.10 | bromodomain PHD finger transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_107130563_107131835 | Bptf | 723 | 0.614208 | 0.63 | 5.6e-08 | Click! |
chr11_107132311_107132628 | Bptf | 342 | 0.850128 | 0.58 | 1.0e-06 | Click! |
chr11_107131900_107132255 | Bptf | 50 | 0.968693 | 0.41 | 1.1e-03 | Click! |
chr11_107114082_107114628 | Bptf | 17567 | 0.146880 | 0.27 | 3.6e-02 | Click! |
chr11_107043683_107043834 | Bptf | 52 | 0.967684 | -0.20 | 1.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_75612178_75613652 | 8.94 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr12_32123180_32123577 | 5.06 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
324 |
0.89 |
chrX_7966827_7967869 | 4.87 |
Gata1 |
GATA binding protein 1 |
562 |
0.55 |
chr10_128015835_128016219 | 4.77 |
Prim1 |
DNA primase, p49 subunit |
831 |
0.38 |
chr13_23505562_23506916 | 4.32 |
n-TStga1 |
nuclear encoded tRNA serine 1 (anticodon TGA) |
11903 |
0.05 |
chr4_115057577_115059724 | 4.32 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr7_97747968_97748165 | 3.84 |
Aqp11 |
aquaporin 11 |
9777 |
0.16 |
chr13_21995061_21995994 | 3.78 |
Prss16 |
protease, serine 16 (thymus) |
9695 |
0.06 |
chr9_48338929_48340200 | 3.67 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr13_23499310_23499461 | 3.60 |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
10528 |
0.06 |
chr11_96946590_96946969 | 3.58 |
D030028A08Rik |
RIKEN cDNA D030028A08 gene |
2467 |
0.13 |
chr9_70680771_70681491 | 3.44 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
2115 |
0.3 |
chr3_51227179_51227330 | 3.32 |
Noct |
nocturnin |
2784 |
0.2 |
chr9_44340460_44342952 | 3.25 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr17_70850016_70850377 | 3.23 |
Tgif1 |
TGFB-induced factor homeobox 1 |
382 |
0.74 |
chr1_58971597_58971799 | 3.20 |
Trak2 |
trafficking protein, kinesin binding 2 |
1731 |
0.25 |
chr17_48281358_48282142 | 3.20 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
9311 |
0.12 |
chr2_4559087_4560437 | 3.19 |
Frmd4a |
FERM domain containing 4A |
6 |
0.98 |
chrY_1285401_1285776 | 3.18 |
Ddx3y |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked |
994 |
0.48 |
chr4_52440277_52440674 | 3.18 |
Smc2 |
structural maintenance of chromosomes 2 |
1206 |
0.35 |
chr10_59875062_59875405 | 3.18 |
Gm7413 |
predicted gene 7413 |
3551 |
0.18 |
chr10_62327314_62328305 | 3.13 |
Hk1 |
hexokinase 1 |
42 |
0.97 |
chrY_4319249_4319558 | 3.12 |
Gm28186 |
predicted gene 28186 |
6821 |
0.23 |
chr5_123750269_123750460 | 3.08 |
Kntc1 |
kinetochore associated 1 |
638 |
0.49 |
chr6_30508580_30508840 | 3.07 |
Tmem209 |
transmembrane protein 209 |
994 |
0.35 |
chr2_84936571_84938205 | 3.06 |
Slc43a3 |
solute carrier family 43, member 3 |
498 |
0.71 |
chr3_52017154_52018268 | 3.00 |
Gm37465 |
predicted gene, 37465 |
13686 |
0.12 |
chr2_9906124_9906915 | 2.98 |
Gm13262 |
predicted gene 13262 |
341 |
0.81 |
chr2_132249750_132250373 | 2.98 |
Pcna |
proliferating cell nuclear antigen |
109 |
0.95 |
chr1_165780024_165780617 | 2.94 |
Gm16565 |
predicted gene 16565 |
755 |
0.43 |
chr13_21994025_21994927 | 2.93 |
Prss16 |
protease, serine 16 (thymus) |
10746 |
0.06 |
chr14_24493007_24493181 | 2.93 |
Rps24 |
ribosomal protein S24 |
1945 |
0.28 |
chr9_70420553_70420960 | 2.93 |
Ccnb2 |
cyclin B2 |
791 |
0.59 |
chr6_56919654_56920133 | 2.91 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
3831 |
0.15 |
chr7_75613990_75614480 | 2.91 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
453 |
0.84 |
chr5_140418009_140418194 | 2.87 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
1227 |
0.35 |
chr3_149844857_149845745 | 2.86 |
Gm31121 |
predicted gene, 31121 |
184905 |
0.03 |
chr1_71650941_71652042 | 2.86 |
Apol7d |
apolipoprotein L 7d |
1346 |
0.36 |
chr9_107951585_107951827 | 2.85 |
Traip |
TRAF-interacting protein |
718 |
0.37 |
chr16_32612449_32612694 | 2.85 |
Tfrc |
transferrin receptor |
2661 |
0.21 |
chr12_65171022_65171635 | 2.83 |
Mis18bp1 |
MIS18 binding protein 1 |
1238 |
0.38 |
chr2_79257648_79258440 | 2.83 |
Itga4 |
integrin alpha 4 |
2097 |
0.38 |
chr5_125409211_125409506 | 2.80 |
Dhx37 |
DEAH (Asp-Glu-Ala-His) box polypeptide 37 |
6539 |
0.12 |
chr9_123480978_123481680 | 2.80 |
Limd1 |
LIM domains containing 1 |
719 |
0.66 |
chr16_92693730_92694957 | 2.79 |
Runx1 |
runt related transcription factor 1 |
1152 |
0.59 |
chr17_40933847_40934523 | 2.77 |
Cenpq |
centromere protein Q |
366 |
0.56 |
chr9_70681690_70681954 | 2.76 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
2806 |
0.25 |
chr6_49261779_49262242 | 2.76 |
Tra2a |
transformer 2 alpha |
2000 |
0.25 |
chr7_100494865_100496416 | 2.75 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
439 |
0.68 |
chr17_40812809_40813139 | 2.74 |
Rhag |
Rhesus blood group-associated A glycoprotein |
1790 |
0.29 |
chr17_71526228_71526780 | 2.72 |
Ndc80 |
NDC80 kinetochore complex component |
286 |
0.56 |
chr2_48947850_48948247 | 2.72 |
Orc4 |
origin recognition complex, subunit 4 |
1183 |
0.42 |
chr9_58248942_58249216 | 2.71 |
Pml |
promyelocytic leukemia |
544 |
0.66 |
chr15_9072970_9073179 | 2.70 |
Nadk2 |
NAD kinase 2, mitochondrial |
1387 |
0.48 |
chr10_111168463_111168874 | 2.67 |
Osbpl8 |
oxysterol binding protein-like 8 |
3866 |
0.17 |
chr3_100682325_100683243 | 2.66 |
Man1a2 |
mannosidase, alpha, class 1A, member 2 |
1829 |
0.22 |
chr7_141133085_141133457 | 2.66 |
Ptdss2 |
phosphatidylserine synthase 2 |
718 |
0.43 |
chr11_121435620_121436084 | 2.65 |
Fn3k |
fructosamine 3 kinase |
884 |
0.47 |
chr3_30010716_30011762 | 2.64 |
Mecom |
MDS1 and EVI1 complex locus |
200 |
0.91 |
chr10_103026340_103027824 | 2.63 |
Alx1 |
ALX homeobox 1 |
1545 |
0.39 |
chr17_74491940_74492091 | 2.61 |
Yipf4 |
Yip1 domain family, member 4 |
171 |
0.94 |
chr10_11284124_11284338 | 2.59 |
Fbxo30 |
F-box protein 30 |
2644 |
0.21 |
chr13_59821306_59822207 | 2.59 |
Tut7 |
terminal uridylyl transferase 7 |
832 |
0.41 |
chr7_120861625_120861776 | 2.59 |
Eef2k |
eukaryotic elongation factor-2 kinase |
10511 |
0.13 |
chr18_10028293_10028725 | 2.58 |
Usp14 |
ubiquitin specific peptidase 14 |
1513 |
0.38 |
chr5_119712542_119712863 | 2.57 |
Tbx3os2 |
T-box 3, opposite strand 2 |
21484 |
0.15 |
chr11_95339521_95340359 | 2.57 |
Fam117a |
family with sequence similarity 117, member A |
7 |
0.96 |
chr9_44336034_44336452 | 2.57 |
Gm44335 |
predicted gene, 44335 |
1138 |
0.16 |
chr1_162217585_162219370 | 2.53 |
Dnm3os |
dynamin 3, opposite strand |
601 |
0.46 |
chr12_69169420_69169571 | 2.53 |
Lrr1 |
leucine rich repeat protein 1 |
653 |
0.41 |
chr4_134511072_134511903 | 2.50 |
Aunip |
aurora kinase A and ninein interacting protein |
488 |
0.68 |
chrX_103472886_103473037 | 2.50 |
Xist |
inactive X specific transcripts |
5705 |
0.09 |
chr6_58643654_58643810 | 2.49 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
3150 |
0.29 |
chr13_51646613_51647088 | 2.48 |
Gm22806 |
predicted gene, 22806 |
1349 |
0.33 |
chr13_51647699_51648388 | 2.47 |
Gm22806 |
predicted gene, 22806 |
156 |
0.94 |
chr3_88835668_88836167 | 2.47 |
Gon4l |
gon-4-like (C.elegans) |
686 |
0.53 |
chr4_46453910_46454934 | 2.47 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
3520 |
0.17 |
chr8_105300231_105300842 | 2.45 |
E2f4 |
E2F transcription factor 4 |
2819 |
0.08 |
chr17_56277120_56277484 | 2.45 |
Ticam1 |
toll-like receptor adaptor molecule 1 |
516 |
0.61 |
chrX_52609355_52610313 | 2.44 |
Gpc3 |
glypican 3 |
4087 |
0.23 |
chr2_4563526_4563775 | 2.43 |
Frmd4a |
FERM domain containing 4A |
2526 |
0.3 |
chr1_173331444_173331908 | 2.43 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
1826 |
0.27 |
chr2_16410567_16410898 | 2.41 |
Plxdc2 |
plexin domain containing 2 |
53615 |
0.18 |
chr18_64491571_64491861 | 2.40 |
Fech |
ferrochelatase |
1465 |
0.36 |
chr14_79391223_79391374 | 2.37 |
Naa16 |
N(alpha)-acetyltransferase 16, NatA auxiliary subunit |
520 |
0.74 |
chr14_115043258_115044172 | 2.37 |
Mir17 |
microRNA 17 |
44 |
0.47 |
chr18_10532033_10532184 | 2.36 |
Gm24894 |
predicted gene, 24894 |
19298 |
0.15 |
chr18_13973001_13973701 | 2.32 |
Zfp521 |
zinc finger protein 521 |
564 |
0.85 |
chr13_109685202_109686701 | 2.32 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
205 |
0.97 |
chr19_17355077_17356896 | 2.32 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
681 |
0.75 |
chr14_47417001_47417190 | 2.31 |
Dlgap5 |
DLG associated protein 5 |
588 |
0.6 |
chr11_117824833_117825154 | 2.30 |
Tk1 |
thymidine kinase 1 |
824 |
0.3 |
chr16_44015370_44016774 | 2.29 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr11_54026219_54026639 | 2.29 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
1523 |
0.33 |
chr7_16783986_16784158 | 2.28 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
666 |
0.56 |
chr10_97566192_97567945 | 2.28 |
Lum |
lumican |
1940 |
0.32 |
chr7_102444853_102445013 | 2.28 |
Rrm1 |
ribonucleotide reductase M1 |
2890 |
0.14 |
chr18_78122352_78123104 | 2.28 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
603 |
0.79 |
chr6_57822563_57823744 | 2.27 |
Vopp1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
1487 |
0.3 |
chr9_24769617_24771807 | 2.27 |
Tbx20 |
T-box 20 |
962 |
0.56 |
chr3_88775672_88776133 | 2.27 |
5830417I10Rik |
RIKEN cDNA 5830417I10 gene |
686 |
0.37 |
chrY_20931931_20932094 | 2.27 |
Gm29866 |
predicted gene, 29866 |
61645 |
0.13 |
chr10_40125651_40125906 | 2.27 |
Gm25613 |
predicted gene, 25613 |
16316 |
0.13 |
chr12_86305172_86306027 | 2.26 |
4732487G21Rik |
RIKEN cDNA 4732487G21 gene |
407 |
0.85 |
chr7_16239587_16240096 | 2.25 |
C5ar2 |
complement component 5a receptor 2 |
2490 |
0.15 |
chr18_34750681_34751638 | 2.25 |
Cdc25c |
cell division cycle 25C |
349 |
0.63 |
chr11_115899671_115901427 | 2.24 |
Smim5 |
small integral membrane protein 5 |
347 |
0.75 |
chr8_94787281_94787774 | 2.24 |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
15302 |
0.1 |
chr3_135213543_135213709 | 2.24 |
Cenpe |
centromere protein E |
1089 |
0.45 |
chr13_21267754_21268467 | 2.23 |
Gpx5 |
glutathione peroxidase 5 |
24621 |
0.1 |
chr2_84733750_84735007 | 2.23 |
Ypel4 |
yippee like 4 |
151 |
0.89 |
chr17_46282048_46282988 | 2.23 |
Tjap1 |
tight junction associated protein 1 |
138 |
0.92 |
chr2_29935933_29936214 | 2.23 |
Gle1 |
GLE1 RNA export mediator (yeast) |
550 |
0.63 |
chr17_53687597_53687796 | 2.22 |
Sgo1 |
shugoshin 1 |
1582 |
0.25 |
chr5_35160468_35161280 | 2.22 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
55108 |
0.11 |
chr11_95338701_95339435 | 2.22 |
Fam117a |
family with sequence similarity 117, member A |
863 |
0.43 |
chr17_40811481_40812037 | 2.22 |
Rhag |
Rhesus blood group-associated A glycoprotein |
575 |
0.7 |
chr8_85379330_85379498 | 2.20 |
Mylk3 |
myosin light chain kinase 3 |
1564 |
0.3 |
chr4_135439152_135439685 | 2.18 |
Rcan3 |
regulator of calcineurin 3 |
5565 |
0.1 |
chr13_5861556_5863117 | 2.17 |
Klf6 |
Kruppel-like factor 6 |
795 |
0.58 |
chr15_56623773_56623977 | 2.17 |
Has2os |
hyaluronan synthase 2, opposite strand |
66069 |
0.12 |
chr13_21910981_21911607 | 2.17 |
Gm11279 |
predicted gene 11279 |
8138 |
0.07 |
chr11_78301619_78302518 | 2.17 |
Spag5 |
sperm associated antigen 5 |
413 |
0.66 |
chr6_146576853_146577104 | 2.16 |
Fgfr1op2 |
FGFR1 oncogene partner 2 |
225 |
0.82 |
chr2_29870905_29871056 | 2.16 |
2600006K01Rik |
RIKEN cDNA 2600006K01 gene |
663 |
0.47 |
chr13_24501559_24502461 | 2.16 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
485 |
0.79 |
chr13_32965217_32966457 | 2.15 |
Serpinb6b |
serine (or cysteine) peptidase inhibitor, clade B, member 6b |
334 |
0.84 |
chr17_33717847_33717998 | 2.15 |
Marchf2 |
membrane associated ring-CH-type finger 2 |
669 |
0.52 |
chr9_44337580_44338161 | 2.15 |
Hmbs |
hydroxymethylbilane synthase |
105 |
0.88 |
chr17_24708041_24708210 | 2.15 |
Tbl3 |
transducin (beta)-like 3 |
465 |
0.52 |
chr1_131136063_131136570 | 2.14 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
1929 |
0.25 |
chr5_139382341_139382984 | 2.13 |
Gpr146 |
G protein-coupled receptor 146 |
2081 |
0.2 |
chr7_97748648_97749068 | 2.13 |
Aqp11 |
aquaporin 11 |
10569 |
0.16 |
chr10_69786998_69788126 | 2.12 |
Ank3 |
ankyrin 3, epithelial |
106 |
0.98 |
chr11_52396155_52396323 | 2.12 |
9530068E07Rik |
RIKEN cDNA 9530068E07 gene |
189 |
0.93 |
chr10_115817324_115818606 | 2.12 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr1_3822725_3822876 | 2.12 |
Gm27396 |
predicted gene, 27396 |
38867 |
0.17 |
chr19_6056965_6057116 | 2.11 |
Mrpl49 |
mitochondrial ribosomal protein L49 |
39 |
0.86 |
chr18_35556097_35557395 | 2.11 |
Snora74a |
small nucleolar RNA, H/ACA box 74A |
286 |
0.46 |
chr16_56036643_56037310 | 2.10 |
Trmt10c |
tRNA methyltransferase 10C, mitochondrial RNase P subunit |
843 |
0.36 |
chr4_119018831_119019462 | 2.10 |
Gm12862 |
predicted gene 12862 |
18661 |
0.09 |
chr1_34440536_34440687 | 2.10 |
Imp4 |
IMP4, U3 small nucleolar ribonucleoprotein |
570 |
0.44 |
chr7_27449283_27449434 | 2.09 |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
1297 |
0.24 |
chr8_80867565_80868184 | 2.08 |
Gm31105 |
predicted gene, 31105 |
12066 |
0.18 |
chr10_39134662_39135000 | 2.08 |
Tube1 |
tubulin, epsilon 1 |
763 |
0.43 |
chr3_121968308_121968529 | 2.07 |
Arhgap29 |
Rho GTPase activating protein 29 |
589 |
0.76 |
chr5_143819014_143819653 | 2.07 |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
1386 |
0.38 |
chr4_139616812_139617223 | 2.06 |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
5849 |
0.15 |
chr7_103812474_103812838 | 2.06 |
Hbb-bt |
hemoglobin, beta adult t chain |
1340 |
0.18 |
chr12_91745342_91746056 | 2.05 |
Ston2 |
stonin 2 |
385 |
0.85 |
chr18_12258021_12258704 | 2.05 |
Ankrd29 |
ankyrin repeat domain 29 |
13335 |
0.15 |
chr13_59766981_59767805 | 2.05 |
Isca1 |
iron-sulfur cluster assembly 1 |
2084 |
0.13 |
chr3_95872000_95872225 | 2.04 |
C920021L13Rik |
RIKEN cDNA C920021L13 gene |
581 |
0.35 |
chr5_88767166_88767376 | 2.03 |
Dck |
deoxycytidine kinase |
2088 |
0.25 |
chr6_66536430_66536632 | 2.03 |
Mad2l1 |
MAD2 mitotic arrest deficient-like 1 |
853 |
0.49 |
chr7_100465236_100467118 | 2.03 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr13_47104057_47104340 | 2.03 |
Dek |
DEK oncogene (DNA binding) |
1632 |
0.24 |
chr6_35994529_35994687 | 2.03 |
Gm23273 |
predicted gene, 23273 |
19278 |
0.26 |
chr13_104937937_104938327 | 2.00 |
Gm4938 |
predicted pseudogene 4938 |
19352 |
0.22 |
chrX_106188534_106190478 | 2.00 |
Pgk1 |
phosphoglycerate kinase 1 |
2122 |
0.24 |
chr11_102554998_102555286 | 2.00 |
Gpatch8 |
G patch domain containing 8 |
1034 |
0.35 |
chr10_91168026_91168420 | 2.00 |
Tmpo |
thymopoietin |
2239 |
0.27 |
chr11_80382987_80383184 | 2.00 |
Zfp207 |
zinc finger protein 207 |
194 |
0.93 |
chr7_104352827_104353391 | 1.99 |
Trim12c |
tripartite motif-containing 12C |
229 |
0.84 |
chr2_155518893_155519044 | 1.99 |
Ggt7 |
gamma-glutamyltransferase 7 |
731 |
0.36 |
chr10_67185515_67186724 | 1.99 |
Jmjd1c |
jumonji domain containing 1C |
366 |
0.89 |
chr16_91649035_91649324 | 1.99 |
Son |
Son DNA binding protein |
1294 |
0.27 |
chr13_100784724_100784958 | 1.99 |
Ccnb1 |
cyclin B1 |
762 |
0.52 |
chr9_120116762_120117051 | 1.99 |
Slc25a38 |
solute carrier family 25, member 38 |
1917 |
0.15 |
chr13_104287829_104288814 | 1.99 |
Adamts6 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6 |
346 |
0.9 |
chr9_35570876_35571027 | 1.98 |
Hyls1 |
HYLS1, centriolar and ciliogenesis associated |
553 |
0.42 |
chr9_103305951_103306102 | 1.98 |
Topbp1 |
topoisomerase (DNA) II binding protein 1 |
523 |
0.61 |
chr1_95147766_95147917 | 1.98 |
Gm23181 |
predicted gene, 23181 |
107798 |
0.07 |
chr4_40851422_40852119 | 1.98 |
Gm25931 |
predicted gene, 25931 |
1368 |
0.21 |
chr10_41809155_41809326 | 1.98 |
Cep57l1 |
centrosomal protein 57-like 1 |
367 |
0.67 |
chr1_61402413_61403049 | 1.98 |
9530026F06Rik |
RIKEN cDNA 9530026F06 gene |
24299 |
0.16 |
chr19_32487078_32487229 | 1.97 |
Minpp1 |
multiple inositol polyphosphate histidine phosphatase 1 |
1230 |
0.3 |
chr6_121272598_121272859 | 1.97 |
Gm44148 |
predicted gene, 44148 |
43 |
0.96 |
chr12_4872599_4872933 | 1.97 |
Mfsd2b |
major facilitator superfamily domain containing 2B |
1579 |
0.27 |
chr11_62560636_62561308 | 1.97 |
Gm12280 |
predicted gene 12280 |
5411 |
0.09 |
chr17_25941002_25941267 | 1.97 |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
749 |
0.37 |
chrX_134308189_134308917 | 1.96 |
Cenpi |
centromere protein I |
354 |
0.86 |
chr13_45391878_45392177 | 1.96 |
Mylip |
myosin regulatory light chain interacting protein |
1100 |
0.57 |
chr5_9540094_9540245 | 1.94 |
Gm42455 |
predicted gene 42455 |
62438 |
0.13 |
chr2_152412768_152412962 | 1.94 |
Zcchc3 |
zinc finger, CCHC domain containing 3 |
2162 |
0.14 |
chr7_16240148_16240434 | 1.94 |
C5ar2 |
complement component 5a receptor 2 |
2040 |
0.17 |
chr2_127831110_127831451 | 1.94 |
Bub1 |
BUB1, mitotic checkpoint serine/threonine kinase |
524 |
0.74 |
chr17_9905595_9906679 | 1.94 |
Gm34799 |
predicted gene, 34799 |
23630 |
0.17 |
chr13_23521181_23522582 | 1.93 |
n-TStga1 |
nuclear encoded tRNA serine 1 (anticodon TGA) |
3739 |
0.06 |
chr12_84222267_84223066 | 1.93 |
Elmsan1 |
ELM2 and Myb/SANT-like domain containing 1 |
3785 |
0.13 |
chr2_142290444_142290595 | 1.93 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
113912 |
0.07 |
chr5_34337686_34337837 | 1.93 |
Rnf4 |
ring finger protein 4 |
442 |
0.74 |
chr15_103238582_103238784 | 1.93 |
Cbx5 |
chromobox 5 |
1133 |
0.3 |
chr1_174173602_174173839 | 1.92 |
Spta1 |
spectrin alpha, erythrocytic 1 |
944 |
0.38 |
chr15_80081033_80081744 | 1.92 |
Rpl3 |
ribosomal protein L3 |
907 |
0.27 |
chr8_119918651_119919036 | 1.92 |
Usp10 |
ubiquitin specific peptidase 10 |
7986 |
0.17 |
chr9_48336880_48337084 | 1.91 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
3852 |
0.25 |
chr11_48823797_48824842 | 1.91 |
Trim7 |
tripartite motif-containing 7 |
1821 |
0.16 |
chr18_38249009_38249288 | 1.91 |
1700086O06Rik |
RIKEN cDNA 1700086O06 gene |
730 |
0.42 |
chr7_141230011_141230393 | 1.90 |
Phrf1 |
PHD and ring finger domains 1 |
1413 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.1 | 6.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.0 | 5.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.5 | 3.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.3 | 1.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.3 | 3.8 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.2 | 3.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.2 | 3.5 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.1 | 3.2 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.0 | 1.0 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) |
1.0 | 3.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.0 | 5.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.0 | 1.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.9 | 4.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.9 | 1.9 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.9 | 2.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.9 | 3.6 | GO:0003166 | bundle of His development(GO:0003166) |
0.9 | 2.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.9 | 2.7 | GO:0042117 | monocyte activation(GO:0042117) |
0.9 | 2.7 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.9 | 2.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.8 | 2.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 2.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 4.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.8 | 3.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 2.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.8 | 2.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.8 | 2.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.8 | 1.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.8 | 3.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.8 | 3.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 3.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.7 | 3.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.7 | 2.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.7 | 2.8 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.7 | 3.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.7 | 2.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.7 | 2.1 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.7 | 1.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.7 | 2.7 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.7 | 2.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.7 | 2.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 | 3.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.7 | 3.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.7 | 2.7 | GO:0032202 | telomere assembly(GO:0032202) |
0.7 | 3.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.7 | 2.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.7 | 2.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.7 | 2.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.7 | 1.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 2.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.7 | 2.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 5.7 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.6 | 1.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.6 | 1.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.6 | 1.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 1.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.6 | 1.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.6 | 0.6 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.6 | 1.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.6 | 1.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 0.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.6 | 3.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.6 | 1.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.6 | 1.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 1.8 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.6 | 4.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.6 | 1.7 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.6 | 1.7 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.6 | 1.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.6 | 2.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 1.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.6 | 1.7 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.6 | 1.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.6 | 1.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 1.7 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 1.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.6 | 1.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 1.7 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.6 | 2.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 2.2 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.6 | 2.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.6 | 0.6 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.6 | 2.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.6 | 1.7 | GO:0046618 | drug export(GO:0046618) |
0.5 | 1.6 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 2.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.5 | 1.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 2.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 2.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.5 | 2.2 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.5 | 5.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 2.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.5 | 2.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.5 | 4.7 | GO:0009650 | UV protection(GO:0009650) |
0.5 | 1.0 | GO:0015677 | copper ion import(GO:0015677) |
0.5 | 2.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 2.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.5 | 3.6 | GO:0042148 | strand invasion(GO:0042148) |
0.5 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.5 | 4.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 1.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 2.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.5 | 1.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.5 | 2.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.5 | 3.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.5 | 1.5 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 3.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 2.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 3.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 1.0 | GO:0036491 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.5 | 1.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 1.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.5 | 2.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.5 | 2.4 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.5 | 4.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.5 | 3.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 1.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 1.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 1.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.5 | 2.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.5 | 1.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 0.9 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.5 | 2.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 2.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.5 | 2.8 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.5 | 1.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 0.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.5 | 2.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 1.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.5 | 4.1 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.5 | 0.9 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.5 | 2.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 2.7 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 2.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 1.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 2.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 0.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.4 | 1.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.4 | 3.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.4 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 0.9 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 1.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 0.4 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 1.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 1.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 0.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 1.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 | 3.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 0.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 1.3 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 0.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 1.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 1.7 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.4 | 1.3 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.4 | 1.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.4 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 0.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.4 | 3.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 1.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 0.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 0.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.4 | 1.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 1.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 0.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 | 2.8 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.4 | 1.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 1.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.4 | 2.4 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.4 | 1.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 2.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 0.4 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.4 | 1.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 1.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 2.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.4 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 1.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.4 | 1.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 3.5 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 0.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.4 | 1.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 2.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 1.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.4 | 1.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 12.1 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.4 | 6.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.4 | 1.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.4 | 0.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 4.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 1.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 3.0 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
0.4 | 7.0 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 0.7 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 1.4 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.4 | 1.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 2.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 1.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 1.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 1.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 0.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 0.7 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 1.8 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.3 | 1.4 | GO:0044838 | cell quiescence(GO:0044838) |
0.3 | 1.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 1.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.3 | 6.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.3 | 1.7 | GO:0015879 | carnitine transport(GO:0015879) |
0.3 | 1.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 2.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 4.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.7 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 10.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 1.0 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 1.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 1.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 2.0 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.3 | 1.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 1.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 0.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 1.0 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.3 | 0.7 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 1.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 2.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 0.3 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.3 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.3 | 2.0 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 2.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 0.3 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 0.7 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 3.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 1.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.6 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 1.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 1.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 1.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 1.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 2.9 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.3 | 4.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 1.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 1.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 1.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 2.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.3 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 6.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 0.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 4.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 1.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 0.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 1.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.3 | 7.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.9 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 0.9 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 2.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 2.5 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.3 | 0.3 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.3 | 2.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 2.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.3 | 1.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 0.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 0.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 1.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 2.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 4.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 0.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 2.5 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.3 | 1.2 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.3 | 0.3 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 2.4 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.3 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 1.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.6 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 4.8 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.3 | 2.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 0.9 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.9 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.3 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 0.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 0.6 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.3 | 1.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 0.9 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 2.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 2.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 0.3 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 0.6 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.3 | 5.0 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 0.3 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.3 | 0.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 0.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 0.3 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 2.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 0.3 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.3 | 0.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 1.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 0.9 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.3 | 7.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 0.9 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.3 | 0.6 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 3.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 1.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 2.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 2.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 1.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 0.3 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 1.7 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.3 | 1.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 2.3 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.3 | 2.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 0.8 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 1.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.1 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 1.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 2.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 1.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.6 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.3 | 2.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 0.3 | GO:0061197 | fungiform papilla morphogenesis(GO:0061197) |
0.3 | 0.6 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 1.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 2.5 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.3 | 1.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 0.5 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 0.8 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 2.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.3 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.3 | 1.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.8 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 2.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 1.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 0.3 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.3 | 0.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 2.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.3 | 1.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 2.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 2.3 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.3 | 4.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 0.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.3 | 6.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 1.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 1.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.5 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.3 | 6.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.3 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 0.8 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.3 | 1.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 1.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 1.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.5 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 0.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 5.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 1.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 1.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.5 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.5 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 2.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 1.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 1.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 1.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 1.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.2 | 1.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 1.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 1.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 1.4 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.7 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 4.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.5 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.2 | 0.9 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 3.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 3.0 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.2 | 0.2 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 2.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 0.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 1.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.2 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.2 | 0.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 6.3 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 0.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 0.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.2 | 0.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 1.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 0.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 5.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.7 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.2 | 8.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 1.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.7 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 5.7 | GO:0043038 | amino acid activation(GO:0043038) |
0.2 | 1.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 1.8 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.4 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.2 | 0.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 1.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 8.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.2 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 0.4 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.2 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.2 | 0.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.2 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.2 | 0.6 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 1.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.2 | 0.6 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.9 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.2 | 0.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.1 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 3.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 1.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 1.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 4.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 1.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.6 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 1.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.6 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 1.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.8 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 1.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.6 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 2.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 2.7 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 1.7 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.2 | 0.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 0.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 2.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 1.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 1.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 4.0 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.2 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.2 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.8 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 1.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 1.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 1.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 9.8 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.2 | 0.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.8 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.4 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.2 | 3.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 0.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 1.2 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 1.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.2 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 2.4 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.2 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.2 | 0.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 1.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.2 | GO:0045472 | response to ether(GO:0045472) |
0.2 | 1.4 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.2 | 0.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 1.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 14.0 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.2 | 1.9 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.2 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.4 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 0.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 0.8 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.2 | 0.2 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.2 | 0.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.2 | 0.6 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 0.7 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 2.8 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 0.2 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.2 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.7 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 2.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 1.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.2 | 0.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.2 | 4.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 0.2 | GO:2000409 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 4.2 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.2 | 0.7 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.2 | 1.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 2.1 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 3.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 0.4 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 0.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.9 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.5 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 1.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.7 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.2 | GO:0010743 | macrophage derived foam cell differentiation(GO:0010742) regulation of macrophage derived foam cell differentiation(GO:0010743) |
0.2 | 0.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.2 | 0.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 2.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 5.3 | GO:0009060 | aerobic respiration(GO:0009060) |
0.2 | 1.0 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.5 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 1.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 8.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 1.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 1.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 1.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 0.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 0.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 1.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 0.5 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.2 | 1.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 0.2 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.2 | 0.3 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 1.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 1.0 | GO:1902110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
0.2 | 1.7 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 0.2 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.2 | 2.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.3 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 1.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.7 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.2 | 1.0 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.2 | 0.3 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.2 | 0.3 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 1.8 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 1.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 1.5 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.2 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.5 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 1.8 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 0.5 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 1.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.8 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.3 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 0.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.2 | 0.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.2 | 1.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.8 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.2 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 1.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.2 | 0.9 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.2 | 2.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 1.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.5 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 1.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 2.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 3.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 1.9 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.2 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.6 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 3.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 0.6 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.2 | 0.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 1.4 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.3 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.2 | 0.5 | GO:0060872 | semicircular canal development(GO:0060872) |
0.2 | 3.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 1.8 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.2 | 0.5 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 6.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.5 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 0.3 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.2 | 2.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.2 | 0.3 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.2 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.5 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.3 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 0.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 9.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 1.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.7 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 4.8 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.1 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.3 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 28.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 3.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.9 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.6 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 3.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 1.6 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 2.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 1.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.4 | GO:0071599 | otic vesicle development(GO:0071599) |
0.1 | 1.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 1.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 2.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 1.8 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 2.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 1.3 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.5 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.9 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 2.6 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.1 | 2.5 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 1.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 1.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 4.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 1.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:1903660 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 15.7 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 0.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.1 | 0.4 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.4 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.8 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 4.9 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.1 | GO:0009217 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.1 | 0.6 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 1.0 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.1 | 1.0 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.6 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 1.1 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.2 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 0.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.9 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.1 | 1.7 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.4 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 1.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.6 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 1.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 2.9 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.8 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.3 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.7 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.9 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.1 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.1 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 2.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.3 | GO:0002248 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.7 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.1 | GO:0090186 | regulation of pancreatic juice secretion(GO:0090186) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.6 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.8 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 2.1 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 3.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 1.6 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.8 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.2 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 1.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 1.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 1.1 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 0.6 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 1.3 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.1 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.8 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.2 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.1 | 0.2 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 1.7 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.7 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 0.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 0.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 1.6 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.1 | 1.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 1.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.6 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.9 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 1.9 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.1 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.1 | 0.5 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.1 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 0.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.2 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.1 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 2.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.1 | 0.2 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.3 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.2 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.1 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.3 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.4 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.1 | 0.1 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.7 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 2.0 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.3 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 2.2 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 3.4 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.8 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.1 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.5 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 3.5 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.2 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.4 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 1.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.7 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 1.0 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 3.5 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.4 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:1990776 | angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.4 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.2 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.1 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.5 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.1 | 0.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.1 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.1 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.2 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 1.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.1 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 0.1 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.2 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.5 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.7 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.3 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.1 | GO:0072141 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 1.4 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.7 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.7 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.1 | 0.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.9 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.9 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.2 | GO:0090178 | establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
0.1 | 0.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 2.0 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.3 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.1 | 0.2 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.1 | 0.1 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.1 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 1.7 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.4 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 1.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 1.0 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.2 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.9 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.2 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.1 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.5 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0072666 | establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.8 | GO:0006757 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.1 | 0.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 1.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.1 | GO:0036394 | amylase secretion(GO:0036394) |
0.1 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.4 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.2 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.0 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.0 | 1.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 2.8 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.0 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.8 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.0 | 0.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.1 | GO:0046134 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.0 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.0 | 0.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.1 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.0 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 1.2 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.0 | 0.1 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.2 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.0 | 0.1 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 6.2 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.0 | GO:0071727 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.1 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.0 | 0.0 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.0 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 3.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.0 | GO:2000858 | renin-angiotensin regulation of aldosterone production(GO:0002018) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.2 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.0 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.0 | 0.2 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 4.7 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.2 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.2 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.1 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.0 | 0.1 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.0 | 0.1 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.0 | 0.0 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.0 | GO:0061308 | cardiac neural crest cell differentiation involved in heart development(GO:0061307) cardiac neural crest cell development involved in heart development(GO:0061308) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.0 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.3 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.1 | GO:0032446 | protein modification by small protein conjugation(GO:0032446) |
0.0 | 0.1 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.3 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.4 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.2 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.0 | 0.1 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.0 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.1 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
0.0 | 0.2 | GO:0070647 | protein modification by small protein conjugation or removal(GO:0070647) |
0.0 | 0.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.1 | GO:1900426 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) regulation of defense response to bacterium(GO:1900424) positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.1 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.0 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.2 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.0 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.0 | 0.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.0 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.0 | GO:0003181 | atrioventricular valve morphogenesis(GO:0003181) |
0.0 | 0.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0045333 | cellular respiration(GO:0045333) |
0.0 | 0.4 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.0 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.0 | 0.0 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.0 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.1 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.0 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.0 | 0.0 | GO:0036503 | ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.0 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.0 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.0 | GO:0019883 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 7.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.1 | 4.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.9 | 3.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.9 | 3.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.8 | 5.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.8 | 2.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.8 | 3.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 3.8 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 2.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.7 | 2.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.7 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.7 | 2.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.7 | 0.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.7 | 4.3 | GO:1990462 | omegasome(GO:1990462) |
0.7 | 1.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.7 | 2.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.6 | 3.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 1.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.6 | 3.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 4.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 2.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.6 | 1.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.5 | 1.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.5 | 2.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 6.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 1.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 1.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 1.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.5 | 3.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 2.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 3.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 2.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 3.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 2.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 3.4 | GO:0070187 | telosome(GO:0070187) |
0.5 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 2.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 3.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.5 | 2.8 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 1.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 1.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.5 | 6.9 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.5 | 1.4 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 4.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 2.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 1.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 7.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 1.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.4 | 1.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 2.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.2 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 4.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 1.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 1.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 2.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.4 | 6.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 4.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 2.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.4 | 3.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 2.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 5.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.4 | 1.5 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 1.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 1.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 2.3 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 3.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 2.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 1.5 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 2.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 1.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 1.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 1.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 2.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 1.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 1.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 1.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 2.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 3.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 3.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 1.0 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 2.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 6.1 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 18.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 1.3 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 1.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 1.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 3.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 3.6 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.3 | 2.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 2.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 1.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 1.6 | GO:0005818 | aster(GO:0005818) |
0.3 | 2.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 4.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 1.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 3.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 0.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 10.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 3.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 5.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 1.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 2.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 1.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 2.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 2.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 0.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.3 | 2.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 1.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 1.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 12.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 17.6 | GO:0000776 | kinetochore(GO:0000776) |
0.3 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 0.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 2.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 0.8 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 5.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 2.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 2.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.3 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 2.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 3.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 2.2 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 3.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 0.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 15.2 | GO:0016605 | PML body(GO:0016605) |
0.3 | 1.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 16.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 9.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 2.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 1.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 1.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 2.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.3 | 12.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.3 | 6.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 3.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 2.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 1.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 5.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 8.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 7.1 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 2.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 2.7 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 2.2 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 2.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 1.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 8.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 2.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 1.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.7 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 1.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 10.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 5.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 4.6 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.4 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 2.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 3.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 1.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 7.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 2.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 1.5 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 4.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 4.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 24.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 6.0 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 7.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.7 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 2.8 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 1.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 4.0 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 0.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 3.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 5.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 4.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 2.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 1.7 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 1.2 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 7.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 1.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 1.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 5.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.2 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 2.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 2.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 2.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.8 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 1.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 9.1 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.2 | 0.2 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.2 | 2.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.1 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.9 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 1.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 3.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 3.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 3.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 2.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.1 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 1.7 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 0.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 13.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 6.3 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 1.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 2.0 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.6 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.2 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.8 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 1.3 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 3.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 7.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 1.4 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 1.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 6.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 3.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 7.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 3.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 4.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 2.3 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 4.9 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 4.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 1.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.3 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 1.9 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 26.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.1 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 6.1 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 5.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.0 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.8 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 0.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.8 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 1.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 1.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.6 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 3.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.8 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 3.4 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 8.2 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.4 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 4.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 2.6 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 9.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 30.5 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 70.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 12.5 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 14.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 2.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.5 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.2 | GO:0043656 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 4.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.1 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 10.6 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.6 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 2.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.8 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 8.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.9 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 3.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 2.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0000803 | sex chromosome(GO:0000803) |
0.0 | 20.5 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.4 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 1.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 12.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.3 | 5.4 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.1 | 8.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 2.8 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.9 | 3.7 | GO:0015265 | urea channel activity(GO:0015265) |
0.9 | 2.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.9 | 3.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.8 | 3.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.8 | 3.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.8 | 2.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 0.8 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.7 | 2.9 | GO:0031433 | telethonin binding(GO:0031433) |
0.7 | 3.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 0.7 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.7 | 0.7 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.7 | 2.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 2.0 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.7 | 4.6 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.6 | 1.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 1.9 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.6 | 1.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 5.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 1.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 4.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.6 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.6 | 2.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.6 | 2.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.5 | 1.6 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.5 | 7.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 3.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 2.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 2.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 1.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 1.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 1.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 5.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 2.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 3.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.5 | 1.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 1.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 1.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.5 | 3.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.5 | 1.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.5 | 7.0 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 0.5 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.5 | 0.5 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.5 | 1.4 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 2.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 1.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 2.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 2.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 4.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.4 | 1.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 4.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 3.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.4 | 1.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 4.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.4 | 2.6 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.4 | 1.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 2.2 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 0.9 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.4 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 1.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 1.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 1.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 2.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 1.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 2.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 1.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 2.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 0.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 0.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.4 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 1.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 2.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 2.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 0.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 1.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 1.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 2.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 1.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 2.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 2.4 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 3.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 0.4 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.4 | 1.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.4 | 1.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 1.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.4 | 1.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 3.1 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.4 | 1.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 5.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 3.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 2.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 0.8 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.4 | 1.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 0.4 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.4 | 1.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 1.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 1.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 1.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 1.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 1.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 0.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 1.3 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 0.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 1.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 2.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 2.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.7 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.3 | 1.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 2.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 2.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 2.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 1.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 1.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 0.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 0.9 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 2.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 3.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 1.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 5.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 3.7 | GO:0043176 | amine binding(GO:0043176) |
0.3 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 2.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 3.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 3.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 3.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 1.5 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 1.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 0.9 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 4.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.3 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 0.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 0.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 2.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 0.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 0.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 10.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 5.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 0.3 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.3 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 2.3 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 0.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 2.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 0.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 3.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.1 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 0.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 1.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 3.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 8.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 5.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 3.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 1.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 1.4 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.3 | 0.8 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 2.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 2.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 3.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 6.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 0.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 1.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.3 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 5.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 9.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 0.8 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 3.7 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 3.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 3.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 1.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.3 | 3.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 1.8 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.3 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 1.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 2.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 3.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 2.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.5 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.2 | 3.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 4.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 2.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.7 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 2.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 3.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 2.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 1.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.7 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.9 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 1.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.9 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 41.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 11.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.2 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 1.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 4.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 1.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.2 | 0.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 38.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 11.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 3.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 2.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 1.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 5.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 9.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 4.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.5 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.8 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 4.2 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 1.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 3.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 9.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 1.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 2.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.4 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 3.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 2.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 0.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 0.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 1.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 1.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.6 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 2.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 4.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 3.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.2 | 2.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 1.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 3.4 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.2 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 1.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.2 | 3.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 8.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.5 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 1.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 1.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.7 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 1.7 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 0.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 2.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 2.5 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 4.1 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.2 | 2.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.2 | GO:0010340 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.2 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 1.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 4.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.5 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 1.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 0.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 2.7 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 0.3 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 3.9 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 1.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 3.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.2 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 4.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 4.3 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 2.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.7 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.1 | 1.0 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.4 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 1.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 8.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 2.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 2.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.8 | GO:0018502 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 1.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 87.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.5 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.7 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.2 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 1.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 2.7 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 1.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.6 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 12.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 5.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 1.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 4.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 2.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 2.6 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.1 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 1.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 1.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 5.4 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 1.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.6 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 1.1 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 7.3 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 4.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 5.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 2.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 3.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 1.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 2.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.7 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.1 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 1.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 2.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 2.0 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 1.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 2.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.3 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 7.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 2.5 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.3 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 1.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.9 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 4.7 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 1.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.3 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 3.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.3 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.2 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.2 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.2 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 2.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 2.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 1.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 3.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.6 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 7.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.7 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 1.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.7 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 5.8 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 3.6 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.0 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 1.1 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 1.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 3.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 1.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 1.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.0 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 1.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.4 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 1.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 1.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 2.9 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.5 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 1.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.2 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 2.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.5 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.9 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 1.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.4 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.2 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.5 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 8.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 21.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 9.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 9.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 4.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 13.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 1.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 2.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 22.8 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 11.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 0.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 3.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 1.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 2.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 4.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 7.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 4.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 1.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 5.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 3.3 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 1.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 12.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 8.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 5.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 13.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 7.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 5.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 9.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 3.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 3.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 6.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 2.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 1.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 4.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 5.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 2.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 3.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 2.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 2.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 3.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 1.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 0.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 3.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 1.2 | PID ATM PATHWAY | ATM pathway |
0.2 | 2.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 2.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 2.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 4.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 3.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 3.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 2.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 5.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 11.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.7 | 9.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.6 | 6.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.6 | 9.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.6 | 4.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 2.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.5 | 9.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 8.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 3.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 26.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 1.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 0.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 1.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 5.0 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.4 | 4.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.4 | 4.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 2.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 2.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 3.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.4 | 11.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 0.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 4.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 0.7 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.3 | 2.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 2.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 35.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 27.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 1.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 3.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 6.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.3 | 8.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 5.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 5.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 0.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 2.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 5.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 2.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.3 | 2.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 3.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 4.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 2.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 2.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 3.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 4.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 2.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 5.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 2.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 4.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 6.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 3.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 3.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 9.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 3.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 2.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 1.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 4.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 5.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 2.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 18.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 0.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.3 | 0.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.3 | 4.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.3 | 2.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 3.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 3.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.2 | 2.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 9.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 11.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 14.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 2.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 4.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 1.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 0.9 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 2.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 1.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 0.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 5.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.2 | 2.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 2.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 5.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.7 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.2 | 4.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 4.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 1.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 7.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 7.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 1.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 4.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 6.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 1.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 3.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 1.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 1.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 20.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 3.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 2.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 4.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 3.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 0.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 4.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 1.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 10.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 1.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 5.0 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.2 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 1.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 7.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 2.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.6 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.2 | 1.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 3.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 4.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.5 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 2.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 2.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 1.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.6 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 2.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.4 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 2.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.0 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 2.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.7 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.1 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 1.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 3.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 1.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 1.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 2.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |